Clinical Trial Update: Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans [Phase 4]

View source ↗

Summary

Phase 4 trial comparing a fixed-dose aliskiren/hydrochlorothiazide combination with amlodipine for blood pressure reduction in stage 2 hypertension in African A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• NORVASC (amlodipine besylate)
• Tekturna HCT (aliskiren/hydrochlorothiazide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-01-12